Loading company…
Solvemed develops digital biomarkers and analytics for neurology care and drug development.
Solvemed is a Cambridge, UK-based software company founded in 2019 by Hugo Chrost and Michal Wlodarski. It uses computer vision and machine learning to develop diagnostic and predictive digital biomarkers for neurodegenerative diseases. In October 2022, the company raised USD 3.5 million from Apex Ventures, ATMOS Ventures, Preface Ventures, Techni Ventures, and Tensor Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in